LAMP1 has been recently studied as a potential candidate marker of lysosomal alteration in neurodegenerative diseases with decreases shown in CSF in PD [8, 16, 26], although it has been previously reported to be unaltered in FTD [7]. This evidence concerns the gene LAMP1 and Parkinson disease.